Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia

Gordon W. Dewald, Amy L. Juneau, Christopher R. Schad, Ayalew Tefferi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Today, laboratory geneticists help clinical hematologists diagnose chronic granulocytic leukemia (CGL) and monitor the response of patients undergoing treatment. The most common genetic tests for CGL include quantitative cytogenetic studies, fluorescence in situ hybridization with probes for BCR and ABL, Southern blot analysis, and reverse transcriptase polymerase chain reaction. No single genetic testing procedure fulfills all the needs of clinicians who care for patients who have CGL. Thus, it has become important to use combinations of testing methods that are both accurate and cost-effective for any given clinical situation in the diagnosis and treatment of patients with CGL.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalCancer Genetics and Cytogenetics
Volume94
Issue number1
DOIs
StatePublished - Mar 1997

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cytogenetics
Molecular Biology
Genetic Testing
Therapeutics
Southern Blotting
Reverse Transcriptase Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Patient Care
Costs and Cost Analysis

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia. / Dewald, Gordon W.; Juneau, Amy L.; Schad, Christopher R.; Tefferi, Ayalew.

In: Cancer Genetics and Cytogenetics, Vol. 94, No. 1, 03.1997, p. 59-66.

Research output: Contribution to journalArticle

@article{9e974cdc3e564f3d974b5f6247712447,
title = "Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia",
abstract = "Today, laboratory geneticists help clinical hematologists diagnose chronic granulocytic leukemia (CGL) and monitor the response of patients undergoing treatment. The most common genetic tests for CGL include quantitative cytogenetic studies, fluorescence in situ hybridization with probes for BCR and ABL, Southern blot analysis, and reverse transcriptase polymerase chain reaction. No single genetic testing procedure fulfills all the needs of clinicians who care for patients who have CGL. Thus, it has become important to use combinations of testing methods that are both accurate and cost-effective for any given clinical situation in the diagnosis and treatment of patients with CGL.",
author = "Dewald, {Gordon W.} and Juneau, {Amy L.} and Schad, {Christopher R.} and Ayalew Tefferi",
year = "1997",
month = "3",
doi = "10.1016/S0165-4608(96)00292-0",
language = "English (US)",
volume = "94",
pages = "59--66",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia

AU - Dewald, Gordon W.

AU - Juneau, Amy L.

AU - Schad, Christopher R.

AU - Tefferi, Ayalew

PY - 1997/3

Y1 - 1997/3

N2 - Today, laboratory geneticists help clinical hematologists diagnose chronic granulocytic leukemia (CGL) and monitor the response of patients undergoing treatment. The most common genetic tests for CGL include quantitative cytogenetic studies, fluorescence in situ hybridization with probes for BCR and ABL, Southern blot analysis, and reverse transcriptase polymerase chain reaction. No single genetic testing procedure fulfills all the needs of clinicians who care for patients who have CGL. Thus, it has become important to use combinations of testing methods that are both accurate and cost-effective for any given clinical situation in the diagnosis and treatment of patients with CGL.

AB - Today, laboratory geneticists help clinical hematologists diagnose chronic granulocytic leukemia (CGL) and monitor the response of patients undergoing treatment. The most common genetic tests for CGL include quantitative cytogenetic studies, fluorescence in situ hybridization with probes for BCR and ABL, Southern blot analysis, and reverse transcriptase polymerase chain reaction. No single genetic testing procedure fulfills all the needs of clinicians who care for patients who have CGL. Thus, it has become important to use combinations of testing methods that are both accurate and cost-effective for any given clinical situation in the diagnosis and treatment of patients with CGL.

UR - http://www.scopus.com/inward/record.url?scp=0030944550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030944550&partnerID=8YFLogxK

U2 - 10.1016/S0165-4608(96)00292-0

DO - 10.1016/S0165-4608(96)00292-0

M3 - Article

C2 - 9078292

AN - SCOPUS:0030944550

VL - 94

SP - 59

EP - 66

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -